| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $520K | -19.3% |
| Cost of Revenue | $582K | -0.2% |
| Gross Profit | -$62K | -201.6% |
| R&D Expense | $3.7M | +24.4% |
| SG&A Expense | $10.1M | +9.1% |
| Operating Income | -$13.9M | -11.9% |
| Pre-tax Income | -$11.7M | -32.7% |
| Income Tax | $0 | — |
| Net Income | -$11.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -79.0% |
| Accounts Receivable | $70K | -40.2% |
| Inventory | $1.0M | +126.7% |
| Current Assets | $3.4M | -54.0% |
| Total Assets | $3.5M | -54.0% |
| Current Liabilities | $2.2M | +15.1% |
| Total Liabilities | $2.5M | -53.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.0M | -6.0% |
| Capital Expenditures | $5K | -82.8% |
| Investing Cash Flow | -$5K | +82.8% |
| Financing Cash Flow | $7.0M | +545.7% |
| Free Cash Flow | -$11.0M | -5.8% |
| -32.7% |
| EPS (Basic) | -$4.33 | +70.3% |
| EPS (Diluted) | -$4.33 | +70.3% |
| Stockholders' Equity |
| $1.1M |
| -54.9% |